BACKGROUND: Alcoholism is a major psychiatric condition at least partly associated with ethanol (EtOH)-induced cell damage. Although brain cell loss has been reported in subjects with alcoholism, the molecular mechanism is unclear. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and monoamine oxidase B (MAO B) reportedly play a role in cellular dysfunction under stressful conditions and might contribute to EtOH-induced cell damage. METHODS: Expression of GAPDH and MAO B protein was studied in human glioblastoma and neuroblastoma cell lines exposed to physiological concentrations of EtOH. Expression of these proteins was also examined in the prefrontal cortex from human subjects with alcohol dependence and in rats fed with an EtOH diet. Coimmunoprecipitation, subcellular fractionation, and luciferase assay were used to address nuclear GAPDH-mediated MAO B activation. To test the effects of inactivation, RNA interference and pharmacological intervention were used, and cell damage was assessed by terminal deoxynucleotidyl transferase (TdT)-mediated dUTP Nick End Labeling (TUNEL) and hydrogen peroxide measurements. RESULTS: Ethanol significantly increases levels of GAPDH, especially nuclear GAPDH, and MAO B in neuronal cells as well as in human and rat brains. Nuclear GAPDH interacts with the transcriptional activator, transforming growth factor-beta-inducible early gene 2 (TIEG2), and augments TIEG2-mediated MAO B transactivation, which results in cell damage in neuronal cells exposed to EtOH. Knockdown expression of GAPDH or treatment with MAO B inhibitors selegiline (deprenyl) and rasagiline (Azilect) can block this cascade. CONCLUSIONS: Ethanol-elicited nuclear GAPDH augments TIEG2-mediated MAO B, which might play a role in brain damage in subjects with alcoholism. Compounds that block this cascade are potential candidates for therapeutic strategies. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
BACKGROUND:Alcoholism is a major psychiatric condition at least partly associated with ethanol (EtOH)-induced cell damage. Although brain cell loss has been reported in subjects with alcoholism, the molecular mechanism is unclear. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and monoamine oxidase B (MAO B) reportedly play a role in cellular dysfunction under stressful conditions and might contribute to EtOH-induced cell damage. METHODS:Expression of GAPDH and MAO B protein was studied in humanglioblastoma and neuroblastoma cell lines exposed to physiological concentrations of EtOH. Expression of these proteins was also examined in the prefrontal cortex from human subjects with alcohol dependence and in rats fed with an EtOH diet. Coimmunoprecipitation, subcellular fractionation, and luciferase assay were used to address nuclear GAPDH-mediated MAO B activation. To test the effects of inactivation, RNA interference and pharmacological intervention were used, and cell damage was assessed by terminal deoxynucleotidyl transferase (TdT)-mediated dUTP Nick End Labeling (TUNEL) and hydrogen peroxide measurements. RESULTS:Ethanol significantly increases levels of GAPDH, especially nuclear GAPDH, and MAO B in neuronal cells as well as in human and rat brains. Nuclear GAPDH interacts with the transcriptional activator, transforming growth factor-beta-inducible early gene 2 (TIEG2), and augments TIEG2-mediated MAO B transactivation, which results in cell damage in neuronal cells exposed to EtOH. Knockdown expression of GAPDH or treatment with MAO B inhibitors selegiline (deprenyl) and rasagiline (Azilect) can block this cascade. CONCLUSIONS:Ethanol-elicited nuclear GAPDH augments TIEG2-mediated MAO B, which might play a role in brain damage in subjects with alcoholism. Compounds that block this cascade are potential candidates for therapeutic strategies. Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Authors: G Reid McDonald; Alan L Hudson; Susan M J Dunn; Haitao You; Glen B Baker; Randy M Whittal; Jonathan W Martin; Amitabh Jha; Dale E Edmondson; Andrew Holt Journal: Science Date: 2008-11-07 Impact factor: 47.728
Authors: Francesca Ducci; Mary-Anne Enoch; Samuel Funt; Matti Virkkunen; Bernard Albaugh; David Goldman Journal: Alcohol Date: 2007-02 Impact factor: 2.405
Authors: Nilkantha Sen; Makoto R Hara; Michael D Kornberg; Matthew B Cascio; Byoung-Il Bae; Neelam Shahani; Bobby Thomas; Ted M Dawson; Valina L Dawson; Solomon H Snyder; Akira Sawa Journal: Nat Cell Biol Date: 2008-06-15 Impact factor: 28.824
Authors: Xiao-Ming Ou; Deyin Lu; Chandra Johnson; Kevin Chen; Moussa B H Youdim; Grazyna Rajkowska; Jean C Shih Journal: Neurotox Res Date: 2009-05-28 Impact factor: 3.911
Authors: Carlos A Tristan; Adriana Ramos; Neelam Shahani; Francesco E Emiliani; Hidemitsu Nakajima; Christopher C Noeh; Yoshinori Kato; Tadayoshi Takeuchi; Takuya Noguchi; Hisae Kadowaki; Thomas W Sedlak; Koko Ishizuka; Hidenori Ichijo; Akira Sawa Journal: J Biol Chem Date: 2014-11-12 Impact factor: 5.157
Authors: Xiao-Ming Ou; Chandra Johnson; Deyin Lu; Shakevia Johnson; Ian A Paul; Mark C Austin; Abiye H Iyo; Jose Javier Miguel-Hidalgo; Jia Luo; Richard L Bell; Matthew Grunewald; Junming Wang; Donald B Sittman Journal: Neurotox Res Date: 2010-03-05 Impact factor: 3.911
Authors: Matthew Grunewald; Shakevia Johnson; Deyin Lu; Zhe Wang; Gwen Lomberk; Paul R Albert; Craig A Stockmeier; Jeffrey H Meyer; Raul Urrutia; Klaus A Miczek; Mark C Austin; Junming Wang; Ian A Paul; William L Woolverton; Seungmae Seo; Donald B Sittman; Xiao-Ming Ou Journal: J Biol Chem Date: 2012-05-24 Impact factor: 5.157
Authors: Jeremy W Duncan; Shakevia Johnson; Xiao Zhang; Baoying Zheng; Jia Luo; Xiao-Ming Ou; Craig A Stockmeier; Jun Ming Wang Journal: Alcohol Clin Exp Res Date: 2016-09-20 Impact factor: 3.455